AVE8112
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVE8112, covering 2015-10-06 to 2015-10-06. Get the full timeline:
Most recent: Clinical Trial Update: A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease [Phase 1]